Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

880126P

Avanti

DSPE-PEG(2000) Maleimide

Avanti Research™ - A Croda Brand 880126P, powder

Sinônimo(s):

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] (ammonium salt)

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Número CAS:
474922-22-0
Código UNSPSC:
12352211
NACRES:
NA.25
Preço e disponibilidade não estão disponíveis no momento.

Formulário

powder

embalagem

pkg of 1 × 10 mg (880126P-10mg)
pkg of 1 × 100 mg (880126P-100mg)
pkg of 1 × 25 mg (880126P-25mg)
pkg of 1 × 50 mg (880126P-50mg)
pkg of 1 × 500 mg (880126P-500mg)

fabricante/nome comercial

Avanti Research™ - A Croda Brand 880126P

Condições de expedição

dry ice

temperatura de armazenamento

−20°C

cadeia de caracteres SMILES

[H][C@@](COP([O-])(OCCNC(OCCOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO/C=C\NC(CCN(C(C=C1)=O)C1=O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C

InChI

1S/C53H94N3O57P.24C2H4.CH4/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-51(60)66-45-47(71-52(61)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)46-70-114(63,64)69-42-39-55-53(62)65-43-44-68-73-75-77-79-81-83-85-87-89-91-93-95-97-99-101-103-105-107-109-11

Aplicação

DSPE-PEG(2000) maleimide is suitable for conjugation with photon-sensitive cell penetrating peptides (psCPP) to prepare nanostructured lipid carrier.[1] It is also suitable for non-covalently functionalizing oxidized multi-walled carbon nanotubes (O-MWCNs).[2]

Ações bioquímicas/fisiológicas

DSPE-PEG(2000) maleimide is used to prepare conjugated polymer nanoparticles.[3] It is suitable for its use in the synthesis of functional conjugates.[4]

Embalagem

20 mL Clear Glass Screw Cap Vial (880126P-500mg)
5 mL Amber Glass Screw Cap Vial (880126P-100mg)
5 mL Amber Glass Screw Cap Vial (880126P-10mg)
5 mL Amber Glass Screw Cap Vial (880126P-25mg)
5 mL Amber Glass Screw Cap Vial (880126P-50mg)

Informações legais

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Código de classe de armazenamento

11 - Combustible Solids

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Lamentamos, não temos COA para este produto disponíveis online no momento.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 6

1 of 6

DSPE-PEG(2000) PDP Avanti Research™ - A Croda Brand 880127P, powder

Avanti

880127P

DSPE-PEG(2000) PDP

DSPE-PEG(2000) PDP Avanti Research™ - A Croda Brand 880127C

Avanti

880127C

DSPE-PEG(2000) PDP

DSPE-PEG(2000)-DBCO Avanti Research™ - A Croda Brand

Avanti

880229P

DSPE-PEG(2000)-DBCO

MAL-dPEG ®12-DSPE

Sigma-Aldrich

QBD11028

MAL-dPEG ®12-DSPE

DSPE-PEG(2000) Azide Avanti Research™ - A Croda Brand, powder

Avanti

880228P

DSPE-PEG(2000) Azide

18:0 PEG2000 PE Avanti Research™ - A Croda Brand 880120C

Avanti

880120C

18:0 PEG2000 PE

The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2
Ren J, et al.
Biomaterials, 33(11), 3324-3333 (2012)
Conjugated Polymers for Biological and Biomedical Applications, 29-29 (2018)
Thomas Linemann et al.
Pharmaceutics, 5(2), 246-260 (2013-12-05)
The aim of the present study was to evaluate the transfection potential of chitosan-coated, green-fluorescent magnetic nanoparticles (MNPs) (chi-MNPs) after encapsulation inside polyethylglycol (PEG)ylated liposomes that produced lipid-encapsulated chitosan-coated MNPs (lip-MNPs), and also to evaluate how these particles would distribute
Yen Ling Yeow et al.
EMBO molecular medicine, 11(12), e10923-e10923 (2019-11-12)
High extracellular matrix (ECM) content in solid cancers impairs tumour perfusion and thus access of imaging and therapeutic agents. We have devised a new approach to degrade tumour ECM, which improves uptake of circulating compounds. We target the immune-modulating cytokine
Megan Farell et al.
ACS applied materials & interfaces, 12(11), 12407-12416 (2020-02-23)
Combination therapies utilize multiple mechanisms to target cancer cells to minimize cancer cell survival. Graphene provides an ideal platform for combination therapy due to its photothermal properties and high loading capacity for cancer-fighting molecules. Lipid functionalization of graphene extends its
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica